TAC-TIC use of tacrolimus-based regimens in lupus nephritis.

Lupus Sci Med · 2016 · PMC5237713 · PMID 28123768

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although severe infections (RR 0.90, 95% CI 0.48 to 1.69, p=NS) and hyperglycaemia (RR 1.40, 95% CI 0.78 to 2.52, p=NS) were more often reported in the TAC-based treatment group, these results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.